Tanzania - English - Tanzania Medicinces & Medical Devices Authority

mylan laboratories limited, india - emtricitabine , tenofovir disoproxil fumarate - tablets - 300 + 200

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

mylan laboratories limited, india - emtricitabine , tenofovir disoproxil fumarate - tablets - 300 + 200

Uganda - English - National Drug Authority

strides shasun limited - emtricitabine+tenofovir disoproxil fumarate - oral solid ordinary film-coated tablets - 200mg+300mg

Uganda - English - National Drug Authority

macleods pharmaceuticals ltd - emtricitabine + tenofovir disoproxil fumarate - oral solid ordinary tablets - 200mg + 300mg

Uganda - English - National Drug Authority

laurus labs limited - - emtricitabine + tenofovir disoproxil fumarate - oral solid ordinary film-coated tablets - 200mg + 300mg

Zimbabwe - English - Medicines Control Authority

sun pharmaceutical industries limited - emtricitabine; tenofovir disoproxil fumarate - tablet, coated; oral - 200; 300mg

Zimbabwe - English - Medicines Control Authority

lupin limited - emtricitabine; tenofovir disoproxil fumarate - tablet, coated; oral - 200; 300 mg

Zimbabwe - English - Medicines Control Authority

laurus labs limited - emtricitabine; tenofovir disoproxil fumarate - tablet, coated; oral - 200; 300mg

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

unimed sdn bhd - tenofovir disoproxil fumarate -

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - emtricitabine, quantity: 200 mg; tenofovir disoproxil maleate, quantity: 300 mg - tablet, film coated - excipient ingredients: magnesium stearate; lactose monohydrate; colloidal anhydrous silica; iron oxide red; microcrystalline cellulose; hyprolose; titanium dioxide; hypromellose; triacetin; iron oxide yellow; brilliant blue fcf aluminium lake - treatment of hiv-1 infection: tenofovir disoproxil emtricitabine mylan 300/200 is indicated for the treatment of hiv infected adults over the age of 18 years, in combination with other antiretroviral agents. pre-exposure prophylaxis: tenofovir disoproxil emtricitabine mylan 300/200 is indicated in combination with safer sex practices for pre-exposure prophylaxis (prep) to reduce the risk of sexually acquired hiv-1 in adults at high risk. this indication is based on clinical trials in men who have sex with men (msm) at high risk for hiv-1 infection and in heterosexual serodiscordant couples (see clinical studies).